spacer
home > epc > spring 2009 > unravelling the maze
PUBLICATIONS
European Pharmaceutical Contractor

Unravelling the Maze

The recent draft guidance issued by the FDA underscored the importance of patient reported outcomes (PRO) in clinical trials. The guidance focused on evaluating the appropriateness and adequacy of PRO in medical product development to support labelling claims. The guidance laid out a blueprint for the evaluation of PRO data collection methods used during clinical trials. Due to the complex nature of this subject, industry experts found that the guidance raised more questions than it answered.

THE FDA GUIDELINES

The use of PRO data is vital to the FDA when issuing labelling claims. Patient reports can be the only way to reliably collect assessments pertaining to subjective information, such as the perception of pain and fatigue. It is essential that this data be captured efficiently, using a validated and unbiased instrument. The FDA has acknowledged the need for clarification regarding the validation of electronic instruments, and by issuing this guidance, has further highlighted the traditional arguments of paper-based versus electronic methods of data capture.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Rachael King holds an MA in Pharmacology from Cambridge University. She is a qualified ISO9001 Tick-IT lead auditor. She has a background in pharmaceutical research and information technology, with more than 15 years of ePRO and EDC experience. Prior to joining CRF Inc, she worked for etrials as Operations lead, Managing Director and Company Secretary of the UK division. Prior to etrials, Rachael worked for Pfizer UK as a Discovery Scientist, as well as in biology computing, where she specialised in laboratory information, automation systems, and real time data acquisition of physiological signals.

spacer
Rachael King
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

Modular Feeding Systems for Prefilled Syringes and Injection Devices

Dividella

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement